Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Maurizio Zangari

Concepts (494)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
146
2024
2929
10.320
 Why?
Thalidomide
33
2016
377
3.080
 Why?
Boronic Acids
17
2013
182
2.940
 Why?
Pyrazines
17
2013
187
2.940
 Why?
Hematopoietic Stem Cell Transplantation
22
2024
565
2.120
 Why?
Bone Marrow
17
2022
362
1.960
 Why?
Venous Thrombosis
8
2009
90
1.770
 Why?
Antineoplastic Combined Chemotherapy Protocols
31
2024
989
1.750
 Why?
Paraproteinemias
7
2022
72
1.670
 Why?
Angiogenesis Inhibitors
12
2009
187
1.580
 Why?
Humans
160
2024
49974
1.410
 Why?
Protease Inhibitors
7
2011
58
1.400
 Why?
Chromosomes, Human, Pair 1
7
2023
93
1.360
 Why?
Proteasome Inhibitors
6
2016
104
1.310
 Why?
Antineoplastic Agents
20
2024
1171
1.220
 Why?
Alkaline Phosphatase
7
2020
94
1.200
 Why?
Middle Aged
65
2024
12069
1.200
 Why?
Prognosis
39
2024
1942
1.200
 Why?
Aged
62
2024
9310
1.180
 Why?
Neoplasm, Residual
6
2022
165
1.170
 Why?
Transplantation, Autologous
30
2024
466
1.150
 Why?
Thrombosis
6
2013
248
1.090
 Why?
Bone Remodeling
3
2016
150
1.070
 Why?
Bone Diseases
2
2021
99
1.060
 Why?
Osteogenesis
4
2018
352
0.970
 Why?
Male
71
2024
25241
0.940
 Why?
Immunologic Factors
5
2016
114
0.940
 Why?
Female
70
2024
26472
0.920
 Why?
Gene Expression Profiling
21
2023
1032
0.910
 Why?
Anticoagulants
6
2009
250
0.860
 Why?
Peripheral Blood Stem Cell Transplantation
6
2012
53
0.860
 Why?
Melphalan
12
2016
174
0.840
 Why?
Neoplasms, Plasma Cell
4
2024
37
0.840
 Why?
Antibodies, Bispecific
4
2024
60
0.830
 Why?
Activated Protein C Resistance
4
2011
10
0.820
 Why?
Parathyroid Hormone
4
2018
147
0.770
 Why?
Venous Thromboembolism
3
2011
68
0.770
 Why?
Antibodies, Monoclonal
4
2022
459
0.760
 Why?
Monoclonal Gammopathy of Undetermined Significance
7
2023
103
0.740
 Why?
Durapatite
1
2020
24
0.720
 Why?
Adult
40
2024
13236
0.710
 Why?
Disease-Free Survival
21
2019
454
0.700
 Why?
Gene Amplification
1
2019
57
0.690
 Why?
Survival Rate
21
2020
894
0.690
 Why?
Thromboembolism
3
2009
54
0.680
 Why?
Neoplasm Proteins
7
2020
322
0.680
 Why?
Dexamethasone
14
2024
430
0.680
 Why?
Myeloablative Agonists
4
2012
30
0.670
 Why?
Bone and Bones
4
2021
469
0.630
 Why?
Gene Expression Regulation, Neoplastic
12
2021
828
0.630
 Why?
Factor V
4
2011
11
0.630
 Why?
Oligopeptides
3
2018
89
0.630
 Why?
Spinal Fractures
1
2018
38
0.620
 Why?
Thymus Gland
1
2018
42
0.610
 Why?
Retrospective Studies
23
2024
6108
0.610
 Why?
Stem Cell Transplantation
12
2024
181
0.610
 Why?
Treatment Outcome
32
2024
5141
0.610
 Why?
Parathyroidectomy
1
2018
45
0.600
 Why?
Thyroidectomy
1
2018
59
0.600
 Why?
Disease Progression
16
2023
825
0.590
 Why?
Translocation, Genetic
8
2021
264
0.590
 Why?
Clinical Trials as Topic
9
2022
461
0.590
 Why?
Aged, 80 and over
19
2021
3129
0.590
 Why?
Chromosome Aberrations
11
2023
297
0.580
 Why?
Calcification, Physiologic
1
2017
41
0.570
 Why?
Follow-Up Studies
22
2024
2182
0.570
 Why?
Pelvis
1
2017
68
0.560
 Why?
Osteoblasts
6
2020
450
0.550
 Why?
Thrombophilia
4
2009
18
0.540
 Why?
Risk Factors
22
2021
3613
0.530
 Why?
Survival Analysis
13
2021
653
0.520
 Why?
Drug Resistance, Neoplasm
7
2015
308
0.510
 Why?
Chromosome Deletion
6
2023
140
0.500
 Why?
Plasma Cells
9
2023
223
0.500
 Why?
B-Cell Maturation Antigen
6
2024
90
0.490
 Why?
Neoplasms
3
2009
1235
0.490
 Why?
Animals
19
2024
13187
0.480
 Why?
Transplantation Conditioning
7
2019
83
0.480
 Why?
Neoplasm Recurrence, Local
7
2024
614
0.460
 Why?
Receptor, Parathyroid Hormone, Type 1
1
2013
24
0.460
 Why?
Polycythemia Vera
1
2013
6
0.450
 Why?
Hemostasis
3
2008
55
0.440
 Why?
Neovascularization, Pathologic
4
2009
161
0.430
 Why?
Mutation
6
2022
1294
0.410
 Why?
Combined Modality Therapy
17
2024
637
0.410
 Why?
Neutropenia
2
2023
116
0.410
 Why?
Hematopoietic Stem Cells
2
2012
184
0.380
 Why?
Bone Neoplasms
2
2010
179
0.380
 Why?
Amyloidosis
3
2009
79
0.370
 Why?
Evolution, Molecular
2
2021
99
0.360
 Why?
Doxorubicin
7
2009
233
0.360
 Why?
Immunotherapy, Adoptive
4
2024
156
0.350
 Why?
Mice
11
2024
5739
0.340
 Why?
Anti-Anxiety Agents
1
2009
35
0.340
 Why?
In Situ Hybridization, Fluorescence
7
2023
259
0.330
 Why?
Kaplan-Meier Estimate
10
2019
466
0.330
 Why?
Hemorrhagic Disorders
1
2009
5
0.330
 Why?
Cryoglobulinemia
1
2008
13
0.330
 Why?
Biopsy, Needle
1
2009
183
0.320
 Why?
Pain
2
2009
379
0.320
 Why?
Analgesics
1
2009
100
0.310
 Why?
Tumor Microenvironment
4
2023
212
0.310
 Why?
Pulmonary Embolism
1
2009
97
0.310
 Why?
Collagen
2
2020
206
0.310
 Why?
Risk Assessment
7
2023
1259
0.300
 Why?
Hematologic Neoplasms
2
2022
99
0.290
 Why?
Cell Line, Tumor
4
2023
1403
0.290
 Why?
Farnesyltranstransferase
1
2006
5
0.290
 Why?
Vascular Endothelial Growth Factor Receptor-2
2
2004
32
0.290
 Why?
Osteolysis
2
2022
75
0.280
 Why?
Waldenstrom Macroglobulinemia
2
2022
40
0.280
 Why?
Pyrroles
2
2004
69
0.280
 Why?
Risk
4
2014
320
0.280
 Why?
Cell Differentiation
4
2022
651
0.270
 Why?
Neoplasms, Second Primary
2
2024
78
0.270
 Why?
Cell Proliferation
8
2023
1007
0.270
 Why?
Sirolimus
1
2006
62
0.270
 Why?
Time Factors
11
2021
2903
0.270
 Why?
Logistic Models
5
2018
888
0.270
 Why?
Signal Transduction
6
2021
1618
0.270
 Why?
Chromosomes, Human, Pair 17
2
2017
36
0.260
 Why?
Recurrence
10
2021
652
0.260
 Why?
Fluorodeoxyglucose F18
4
2021
192
0.240
 Why?
Plasmacytoma
2
2020
42
0.240
 Why?
Enoxaparin
1
2004
27
0.240
 Why?
Polycomb Repressive Complex 2
2
2021
47
0.240
 Why?
Remission Induction
10
2021
207
0.240
 Why?
Pentaerythritol Tetranitrate
1
2024
6
0.240
 Why?
Indoles
2
2004
278
0.240
 Why?
Vascular Endothelial Growth Factor A
2
2004
201
0.230
 Why?
Prospective Studies
9
2019
2364
0.220
 Why?
Blood Coagulation
1
2003
56
0.220
 Why?
Positron-Emission Tomography
3
2022
295
0.210
 Why?
Immunoglobulin Light Chains
2
2017
81
0.210
 Why?
Proto-Oncogene Proteins B-raf
2
2020
79
0.210
 Why?
Bone Resorption
2
2022
304
0.210
 Why?
Randomized Controlled Trials as Topic
3
2012
549
0.210
 Why?
Hematopoietic Stem Cell Mobilization
3
2008
57
0.210
 Why?
Immunoconjugates
1
2022
38
0.200
 Why?
Drug Approval
1
2022
47
0.200
 Why?
Cell Cycle
2
2021
231
0.200
 Why?
Hemorrhage
3
2009
197
0.200
 Why?
Chromosomal Instability
2
2019
16
0.200
 Why?
Lymphoma, B-Cell
1
2022
63
0.200
 Why?
Epigenomics
1
2021
67
0.200
 Why?
Chromosomes, Human, Pair 13
5
2008
38
0.190
 Why?
Patient Participation
1
2022
66
0.190
 Why?
SOXC Transcription Factors
1
2021
13
0.190
 Why?
Arkansas
5
2021
1977
0.190
 Why?
T-Lymphocytes
4
2024
338
0.190
 Why?
Diffusion Magnetic Resonance Imaging
2
2019
123
0.190
 Why?
Odontoblasts
1
2020
4
0.180
 Why?
Calcium Phosphates
1
2020
5
0.180
 Why?
HL-60 Cells
1
2020
18
0.180
 Why?
U937 Cells
1
2020
14
0.180
 Why?
Etoposide
5
2009
72
0.180
 Why?
K562 Cells
1
2020
42
0.180
 Why?
Genes, Tumor Suppressor
2
2021
73
0.180
 Why?
Kidney Diseases
2
2020
214
0.180
 Why?
NIH 3T3 Cells
1
2020
52
0.180
 Why?
Mammals
1
2020
56
0.180
 Why?
MCF-7 Cells
1
2020
68
0.180
 Why?
Practice Guidelines as Topic
1
2023
449
0.180
 Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.180
 Why?
Protein C
2
2011
18
0.180
 Why?
Leukemia, Plasma Cell
1
2020
33
0.180
 Why?
Myelodysplastic Syndromes
3
2007
81
0.170
 Why?
beta 2-Microglobulin
5
2008
38
0.170
 Why?
HEK293 Cells
1
2020
222
0.170
 Why?
Busulfan
1
2019
18
0.170
 Why?
HeLa Cells
1
2020
250
0.170
 Why?
Cisplatin
6
2009
278
0.170
 Why?
Atrial Fibrillation
1
2022
180
0.170
 Why?
Gene Regulatory Networks
1
2020
107
0.170
 Why?
Hematopoiesis, Extramedullary
1
2019
9
0.170
 Why?
Epigenesis, Genetic
2
2020
374
0.170
 Why?
Imaging, Three-Dimensional
2
2017
151
0.170
 Why?
Healthcare Disparities
1
2022
257
0.170
 Why?
Genome-Wide Association Study
1
2020
166
0.160
 Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.160
 Why?
Fractures, Compression
1
2018
17
0.160
 Why?
Predictive Value of Tests
4
2009
903
0.160
 Why?
Spleen
1
2019
172
0.160
 Why?
Fibrinolysis
2
2009
5
0.160
 Why?
Phosphotransferases
1
2018
16
0.160
 Why?
Genomic Instability
2
2016
92
0.160
 Why?
Blood Coagulation Factors
2
2009
17
0.150
 Why?
Cytokines
3
2007
612
0.150
 Why?
Antineoplastic Agents, Alkylating
6
2008
74
0.150
 Why?
Bacteremia
1
2019
90
0.150
 Why?
Adipocytes
1
2018
121
0.150
 Why?
Gene Rearrangement
1
2018
74
0.150
 Why?
Cell Line
1
2020
1000
0.150
 Why?
Cluster Analysis
4
2012
235
0.150
 Why?
Metaphase
4
2016
44
0.150
 Why?
Hexokinase
1
2017
17
0.150
 Why?
Heparin, Low-Molecular-Weight
2
2007
20
0.150
 Why?
Ultrasonography, Doppler
2
2007
42
0.140
 Why?
Renal Insufficiency
4
2010
109
0.140
 Why?
Fibrinolytic Agents
2
2007
124
0.140
 Why?
Clonal Evolution
1
2016
56
0.130
 Why?
Calcium
1
2018
396
0.130
 Why?
Gene Expression Regulation, Enzymologic
1
2017
181
0.130
 Why?
Tumor Burden
3
2020
132
0.130
 Why?
Tumor Suppressor Protein p53
1
2017
202
0.130
 Why?
Gene Expression
1
2018
609
0.130
 Why?
Disease Models, Animal
4
2016
1455
0.130
 Why?
Genes, Neoplasm
1
2015
30
0.130
 Why?
Multivariate Analysis
7
2021
577
0.130
 Why?
Immunotherapy
2
2016
238
0.130
 Why?
Bone Marrow Transplantation
4
2022
116
0.130
 Why?
Polymorphism, Single Nucleotide
2
2020
485
0.130
 Why?
Gene Dosage
1
2015
78
0.130
 Why?
Salvage Therapy
6
2006
139
0.120
 Why?
Incidence
2
2009
1003
0.120
 Why?
Algorithms
1
2018
615
0.120
 Why?
Osteoclasts
3
2022
425
0.110
 Why?
Cystatin M
2
2024
20
0.110
 Why?
Case-Control Studies
4
2011
1131
0.110
 Why?
Altitude
1
2013
16
0.110
 Why?
Chromosomes, Human, Pair 11
3
2020
54
0.110
 Why?
Janus Kinase 2
1
2013
26
0.110
 Why?
Cross-Sectional Studies
3
2023
1557
0.110
 Why?
Tomography, X-Ray Computed
2
2017
1159
0.110
 Why?
STAT3 Transcription Factor
2
2010
81
0.110
 Why?
Protein-Tyrosine Kinases
3
2018
95
0.110
 Why?
Bone Density Conservation Agents
2
2010
77
0.110
 Why?
Models, Biological
1
2016
727
0.110
 Why?
Creatinine
2
2010
139
0.110
 Why?
Mice, Inbred C57BL
1
2018
1816
0.110
 Why?
Cytogenetic Analysis
6
2014
82
0.100
 Why?
Viremia
1
2012
22
0.100
 Why?
Clone Cells
2
2023
74
0.100
 Why?
Cytomegalovirus Infections
1
2012
34
0.100
 Why?
Models, Genetic
2
2016
170
0.100
 Why?
Clinical Trials, Phase II as Topic
1
2012
43
0.100
 Why?
Clinical Trials, Phase III as Topic
1
2012
43
0.100
 Why?
Viper Venoms
1
2011
7
0.100
 Why?
Drug Evaluation, Preclinical
1
2012
144
0.100
 Why?
Epidemiologic Methods
2
2008
49
0.100
 Why?
NF-kappa B
2
2018
314
0.100
 Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
6
0.090
 Why?
Arsenicals
1
2010
14
0.090
 Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
20
0.090
 Why?
Oxides
1
2010
18
0.090
 Why?
Mutation Rate
2
2021
36
0.090
 Why?
Granulocyte Colony-Stimulating Factor
2
2008
61
0.090
 Why?
Hypercalcemia
1
2010
33
0.090
 Why?
Transplantation, Homologous
4
2003
139
0.090
 Why?
Cyclophosphamide
4
2003
165
0.090
 Why?
Antineoplastic Agents, Hormonal
2
2007
47
0.090
 Why?
Janus Kinase 1
1
2010
17
0.090
 Why?
Anemia
1
2010
68
0.090
 Why?
MAP Kinase Kinase 1
1
2010
23
0.090
 Why?
Administration, Oral
2
2009
426
0.090
 Why?
Cyclin-Dependent Kinases
1
2010
28
0.090
 Why?
Proteinuria
1
2010
39
0.090
 Why?
Alleles
2
2021
250
0.090
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
83
0.090
 Why?
Genomics
2
2023
286
0.090
 Why?
Diphosphonates
1
2010
90
0.090
 Why?
Lorazepam
1
2009
11
0.090
 Why?
Anesthesia, Local
1
2009
15
0.080
 Why?
Hyperhomocysteinemia
1
2009
29
0.080
 Why?
Receptors, Retinoic Acid
1
2009
23
0.080
 Why?
Oxycodone
1
2009
27
0.080
 Why?
Dose-Response Relationship, Drug
3
2008
1376
0.080
 Why?
Prednisone
1
2009
99
0.080
 Why?
Tretinoin
1
2009
53
0.080
 Why?
Hemostatic Techniques
1
2009
28
0.080
 Why?
Plasma Exchange
1
2009
23
0.080
 Why?
Histones
2
2021
312
0.080
 Why?
Vasculitis
1
2008
29
0.080
 Why?
Vincristine
3
2003
89
0.080
 Why?
Syndecan-1
3
2021
72
0.080
 Why?
Transcription Factors
2
2023
561
0.080
 Why?
Biopsy
3
2018
584
0.080
 Why?
Drug Therapy, Combination
1
2009
377
0.080
 Why?
DNA Copy Number Variations
2
2021
110
0.080
 Why?
Cytogenetics
1
2008
23
0.080
 Why?
Carrier Proteins
1
2010
304
0.080
 Why?
Bone Development
1
2009
65
0.080
 Why?
Radiopharmaceuticals
2
2021
209
0.080
 Why?
Pain Measurement
1
2009
240
0.080
 Why?
Staphylococcal Infections
2
2019
268
0.080
 Why?
Platelet Aggregation
1
2008
71
0.080
 Why?
Thrombocytopenia
1
2009
85
0.080
 Why?
Double-Blind Method
1
2009
681
0.080
 Why?
Brain Diseases, Metabolic
1
2007
5
0.070
 Why?
Phlebography
1
2007
61
0.070
 Why?
Hyperammonemia
1
2007
18
0.070
 Why?
Myeloma Proteins
1
2007
24
0.070
 Why?
Antimetabolites
1
2006
13
0.070
 Why?
Cell Communication
2
2023
69
0.070
 Why?
Chi-Square Distribution
1
2007
280
0.070
 Why?
Transcriptome
2
2020
315
0.070
 Why?
Partial Thromboplastin Time
1
2006
12
0.070
 Why?
Magnetic Resonance Imaging
4
2007
1537
0.070
 Why?
Osteoprotegerin
1
2006
52
0.070
 Why?
Heterozygote
1
2006
81
0.070
 Why?
Acetaminophen
1
2009
283
0.070
 Why?
Antibiotics, Antineoplastic
1
2006
78
0.070
 Why?
Gastrointestinal Neoplasms
1
2006
44
0.070
 Why?
Models, Statistical
1
2007
224
0.070
 Why?
Pilot Projects
1
2008
699
0.070
 Why?
Age Factors
3
2005
1087
0.060
 Why?
Femur Head Necrosis
1
2005
18
0.060
 Why?
Neovascularization, Physiologic
1
2005
68
0.060
 Why?
Apoptosis
1
2010
1101
0.060
 Why?
Gene Deletion
2
2003
266
0.060
 Why?
Syndrome
2
2019
237
0.060
 Why?
Ferritins
1
2024
30
0.060
 Why?
Glucuronidase
1
2003
46
0.060
 Why?
Demography
1
2024
93
0.060
 Why?
Myeloid Progenitor Cells
1
2023
18
0.060
 Why?
X-Ray Microtomography
1
2024
77
0.060
 Why?
DNA Methylation
2
2020
548
0.060
 Why?
Receptors, G-Protein-Coupled
1
2024
53
0.060
 Why?
Immunosuppressive Agents
1
2005
221
0.060
 Why?
DNA, Neoplasm
2
2020
147
0.060
 Why?
Antibodies
1
2024
154
0.060
 Why?
Discitis
1
2003
9
0.060
 Why?
Oligonucleotide Array Sequence Analysis
4
2006
411
0.050
 Why?
Myeloproliferative Disorders
1
2003
27
0.050
 Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
 Why?
Antigens, CD34
1
2003
66
0.050
 Why?
Platelet Count
3
2008
72
0.050
 Why?
Tumor Cells, Cultured
3
2010
465
0.050
 Why?
Patients
1
2022
49
0.050
 Why?
Geography
1
2022
61
0.050
 Why?
Rats
1
2009
3305
0.050
 Why?
Leukemia, Myeloid
1
2002
43
0.050
 Why?
Myeloid Differentiation Factor 88
1
2022
33
0.050
 Why?
Receptors, Antigen, T-Cell
1
2022
51
0.050
 Why?
Drug Interactions
1
2002
206
0.050
 Why?
Patient Selection
1
2023
253
0.050
 Why?
Chromosome Disorders
1
2002
35
0.050
 Why?
United States Food and Drug Administration
1
2022
93
0.050
 Why?
Oncogenes
1
2021
57
0.050
 Why?
Phylogeny
1
2022
235
0.050
 Why?
Hypothyroidism
1
2002
54
0.050
 Why?
Enzyme Inhibitors
1
2004
391
0.050
 Why?
Central Nervous System Neoplasms
1
2002
63
0.050
 Why?
RANK Ligand
1
2022
179
0.050
 Why?
Transcriptional Activation
1
2021
121
0.050
 Why?
Cohort Studies
2
2020
1422
0.050
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
92
0.050
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
105
0.050
 Why?
Chromatin
1
2021
151
0.050
 Why?
Antibodies, Monoclonal, Humanized
1
2022
225
0.050
 Why?
Proto-Oncogene Proteins p21(ras)
1
2021
66
0.050
 Why?
Cyclin D2
1
2020
20
0.050
 Why?
Aneuploidy
1
2020
16
0.050
 Why?
Pyrimidines
1
2022
192
0.050
 Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.050
 Why?
Endothelium, Vascular
1
2002
252
0.050
 Why?
Chromosomes, Human, Pair 4
1
2020
31
0.050
 Why?
Gene Expression Regulation, Leukemic
1
2020
33
0.050
 Why?
Histone Code
1
2020
32
0.050
 Why?
Cyclin D1
1
2020
56
0.050
 Why?
ras Proteins
1
2020
64
0.050
 Why?
Genome, Human
1
2021
111
0.050
 Why?
Longitudinal Studies
2
2016
688
0.050
 Why?
Chromosomes, Human, Pair 14
1
2020
75
0.050
 Why?
Protein Kinase Inhibitors
1
2022
204
0.040
 Why?
Transcriptional Elongation Factors
1
2020
18
0.040
 Why?
Postoperative Complications
1
2007
984
0.040
 Why?
Genetic Loci
1
2020
49
0.040
 Why?
Health Status Disparities
1
2022
195
0.040
 Why?
RNA, Messenger
3
2010
1105
0.040
 Why?
DNA Mutational Analysis
1
2020
175
0.040
 Why?
Genetic Variation
1
2020
213
0.040
 Why?
High-Throughput Nucleotide Sequencing
1
2020
169
0.040
 Why?
Neoplastic Stem Cells
2
2015
103
0.040
 Why?
Gram-Positive Bacterial Infections
1
2019
26
0.040
 Why?
Computational Biology
1
2020
214
0.040
 Why?
Pseudomonas Infections
1
2019
48
0.040
 Why?
Proline
1
2018
30
0.040
 Why?
Bone Marrow Cells
2
2014
191
0.040
 Why?
DNA-Binding Proteins
1
2021
427
0.040
 Why?
Recombinant Proteins
2
2010
486
0.040
 Why?
Fluorescent Dyes
1
2018
102
0.040
 Why?
Proteolysis
1
2018
94
0.040
 Why?
Receptor Protein-Tyrosine Kinases
1
2018
51
0.040
 Why?
Promoter Regions, Genetic
1
2020
475
0.040
 Why?
Oncogene Proteins, Fusion
1
2018
58
0.040
 Why?
Extracellular Matrix
1
2018
111
0.040
 Why?
Kidney Function Tests
1
2017
49
0.040
 Why?
Cell Movement
1
2018
247
0.040
 Why?
False Positive Reactions
1
2017
63
0.040
 Why?
Glomerular Filtration Rate
1
2017
111
0.040
 Why?
Amino Acid Sequence
1
2018
585
0.040
 Why?
Genetic Predisposition to Disease
1
2020
510
0.030
 Why?
Genes, ras
1
2016
43
0.030
 Why?
Cell Survival
2
2010
600
0.030
 Why?
Genes, p53
1
2016
51
0.030
 Why?
Mice, SCID
2
2009
175
0.030
 Why?
Glycolysis
1
2016
70
0.030
 Why?
Chromosome Mapping
2
2006
156
0.030
 Why?
Image Interpretation, Computer-Assisted
1
2016
106
0.030
 Why?
Phosphatidylinositol 3-Kinases
1
2016
141
0.030
 Why?
Serum Albumin
2
2008
58
0.030
 Why?
Syndecans
2
2006
34
0.030
 Why?
Proteoglycans
2
2006
80
0.030
 Why?
Drug Monitoring
1
2015
77
0.030
 Why?
Cells, Cultured
1
2018
1573
0.030
 Why?
Myocardium
1
2017
436
0.030
 Why?
Interspersed Repetitive Sequences
1
2014
8
0.030
 Why?
Karyotype
1
2014
18
0.030
 Why?
Proportional Hazards Models
2
2006
402
0.030
 Why?
Membrane Glycoproteins
2
2006
240
0.030
 Why?
Transplantation Chimera
2
2003
15
0.030
 Why?
Infusions, Intravenous
2
2003
206
0.030
 Why?
Neoplasm Staging
2
2007
740
0.030
 Why?
RNA Interference
1
2013
179
0.030
 Why?
Cytomegalovirus
1
2012
27
0.030
 Why?
Viral Load
1
2012
76
0.030
 Why?
Virus Activation
1
2012
32
0.030
 Why?
Graft vs Host Disease
2
2003
75
0.030
 Why?
United States
1
2022
4860
0.020
 Why?
Interferon Regulatory Factor-1
1
2010
14
0.020
 Why?
Cell Growth Processes
1
2010
22
0.020
 Why?
Antiviral Agents
1
2012
173
0.020
 Why?
CDC2-CDC28 Kinases
1
2010
12
0.020
 Why?
Femur
1
2010
133
0.020
 Why?
Long-Term Care
1
2010
51
0.020
 Why?
Peripheral Nervous System Diseases
1
2010
57
0.020
 Why?
RNA, Small Interfering
1
2010
215
0.020
 Why?
Down-Regulation
1
2010
348
0.020
 Why?
Bone Diseases, Metabolic
1
2010
74
0.020
 Why?
Cell Transformation, Neoplastic
1
2010
177
0.020
 Why?
Abnormalities, Multiple
1
2010
167
0.020
 Why?
Protein Isoforms
1
2009
119
0.020
 Why?
Ploidies
1
2008
11
0.020
 Why?
Ligands
1
2009
204
0.020
 Why?
Rabbits
1
2009
370
0.020
 Why?
Hemoglobins
1
2008
107
0.020
 Why?
Polyethylene Glycols
1
2008
93
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
595
0.020
 Why?
Age Distribution
1
2007
168
0.020
 Why?
Ammonia
1
2007
73
0.020
 Why?
C-Reactive Protein
1
2008
142
0.020
 Why?
Diagnosis, Differential
1
2010
1037
0.020
 Why?
Mass Screening
1
2010
353
0.020
 Why?
Multigene Family
1
2006
56
0.020
 Why?
Blood Proteins
1
2007
82
0.020
 Why?
Bone Density
1
2009
379
0.020
 Why?
Cyclin D
1
2006
18
0.020
 Why?
Brain
2
2007
1328
0.020
 Why?
Cyclins
1
2006
38
0.020
 Why?
RNA, Neoplasm
1
2006
44
0.020
 Why?
Evidence-Based Medicine
1
2007
247
0.020
 Why?
Leukemia, Myeloid, Acute
1
2007
185
0.020
 Why?
Radiography
1
2007
489
0.020
 Why?
Coculture Techniques
1
2006
146
0.020
 Why?
Data Interpretation, Statistical
1
2006
158
0.020
 Why?
Neoplasms, Experimental
1
2006
114
0.020
 Why?
Interferon-alpha
1
2005
47
0.020
 Why?
Survivors
1
2006
126
0.020
 Why?
Databases, Factual
1
2007
658
0.010
 Why?
Mice, Transgenic
1
2006
555
0.010
 Why?
Monosomy
1
2003
5
0.010
 Why?
Odds Ratio
1
2005
545
0.010
 Why?
Trisomy
1
2003
31
0.010
 Why?
History, 21st Century
1
2003
56
0.010
 Why?
Endothelial Growth Factors
1
2003
9
0.010
 Why?
Vascular Endothelial Growth Factors
1
2003
15
0.010
 Why?
Lymphokines
1
2003
20
0.010
 Why?
Fusion Proteins, bcr-abl
1
2003
20
0.010
 Why?
Stem Cell Factor
1
2003
7
0.010
 Why?
History, 20th Century
1
2003
99
0.010
 Why?
Confidence Intervals
1
2003
156
0.010
 Why?
Lymphocyte Transfusion
1
2003
10
0.010
 Why?
Probability
1
2003
164
0.010
 Why?
Interphase
1
2003
10
0.010
 Why?
Diploidy
1
2003
26
0.010
 Why?
Leukocyte Count
1
2003
70
0.010
 Why?
Back Pain
1
2003
39
0.010
 Why?
Interferons
1
2002
38
0.010
 Why?
Sex Factors
1
2005
691
0.010
 Why?
Cell Count
1
2003
147
0.010
 Why?
Intercellular Signaling Peptides and Proteins
1
2003
104
0.010
 Why?
Drug Administration Schedule
1
2003
376
0.010
 Why?
Thyroid Function Tests
1
2002
24
0.010
 Why?
Thyrotropin
1
2002
47
0.010
 Why?
Prevalence
1
2005
944
0.010
 Why?
Tissue Donors
1
2003
111
0.010
 Why?
Neutrophils
1
2003
145
0.010
 Why?
Fatal Outcome
1
2002
195
0.010
 Why?
Cell Division
1
2002
292
0.010
 Why?
Reoperation
1
2003
454
0.010
 Why?
Acute Disease
1
2002
366
0.010
 Why?
Up-Regulation
1
2002
452
0.010
 Why?
Anti-Bacterial Agents
1
2003
744
0.010
 Why?
Zangari's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (494) concept(s)
_
Co-Authors Expand Description
See all (53) people
_
Similar People Expand Description
See all (30) people
_
Same Department Expand Description
Search Department